Products

Differential Bio is pioneering the integration of biology and computation to revolutionize biomanufacturing. Their platform serves as the computational backbone for applying BioAI to regenerative manufacturing, enabling a shift from traditional trial-and-error methods to predictive, digital-first experimentation. This approach accelerates the development of biomanufactured products, making the process faster, more cost-effective, and smarter.

Achira is a biotechnology company revolutionizing drug discovery by developing atomistic foundation simulation models that integrate machine learning, quantum chemistry, and physics-based simulations. This innovative approach aims to overcome the limitations of traditional biomolecular simulations and the data constraints of pure machine learning models, thereby accelerating the identification and development of therapeutic compounds.

Leash Biosciences is a biotechnology company dedicated to revolutionizing drug discovery by integrating machine learning with extensive biochemical data. By screening millions of compounds against thousands of proteins, Leash generates billions of data points, creating a rich dataset ideal for training advanced machine learning models. This approach aims to bridge the existing data gap in medicinal chemistry, facilitating the rapid design of novel small molecule therapeutics.

ReactWise Collaborate is a specialized solution designed to enhance teamwork and communication within chemical process optimization projects. By providing shared dashboards and real-time data access, it ensures seamless collaboration among chemists, engineers, and management. This platform facilitates efficient interaction with external partners, promoting continuous knowledge transfer and streamlined project execution.

PolyModels Hub is a British software startup specializing in SaaS solutions for pharmaceutical process development. Their platform leverages artificial intelligence to assist scientists in modeling, simulating, and gaining insights across all protocols involved in transforming chemical compounds into safe drug products.

LabGenius is a pioneering biopharmaceutical company that leverages machine learning and automation to revolutionize the discovery and optimization of complex protein therapeutics. Their proprietary platform, EVA™, integrates advanced technologies from machine learning, synthetic biology, and robotics to design, build, and test novel antibody-based treatments efficiently. This approach enables the rapid evaluation of vast numbers of multispecific antibodies, leading to the identification of high-

Nextmol is a cloud-based computational chemistry platform designed to accelerate the development of new materials and chemicals. By leveraging advanced molecular modeling and simulation techniques, Nextmol enables researchers and scientists to predict the properties and behavior of molecules, facilitating the design of innovative products across various industries.

AQBioSim, developed by SandboxAQ, is an advanced platform that revolutionizes drug discovery and development by integrating artificial intelligence (AI) and quantum-inspired technologies. This comprehensive solution employs Large Quantitative Models (LQMs) to simulate molecular interactions, enabling precise predictions of drug compound behaviors. By accelerating the identification and optimization of both small molecules and biologics, AQBioSim significantly reduces research and development tim

AQChemSim is an advanced computational platform developed by SandboxAQ that revolutionizes the discovery and optimization of chemicals and materials. By integrating Large Quantitative Models (LQMs) derived from artificial intelligence and physics-based methodologies, AQChemSim accelerates innovation across various industries, including catalyst development, battery technology, and alloy design. This approach offers a groundbreaking alternative to traditional materials discovery by combining data

Terray Therapeutics is a biotechnology company revolutionizing small molecule drug discovery by integrating ultra-high throughput experimentation with generative AI. Their proprietary tNova platform combines precise chemical data generation with advanced computational analysis, enabling the rapid identification and optimization of novel therapeutics. This approach accelerates the drug development process, reduces costs, and enhances success rates, addressing complex therapeutic challenges across

Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at a

CellChorus offers dynamic single-cell analysis through its TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids) platform, which utilizes visual AI to evaluate how thousands of individual cells move, activate, interact, kill, and survive over time. This technology provides a comprehensive understanding of cellular function, state, and phenotype, surpassing traditional methods that often lack the ability to integrate dynamic cellular behavior with molecular insights at the single-cell level.

CytoReason is a pioneering technology company specializing in the development of computational disease models that simulate human diseases at the cellular and tissue levels. By integrating vast datasets, including omics data and cell-focused natural language processing, CytoReason's platform provides a comprehensive understanding of disease mechanisms, patient variability, and treatment effects. This innovative approach enables pharmaceutical and biotech companies to identify new therapeutic tar

Albert Invent's Laboratory Information Management System (LIMS) is designed to unify and streamline laboratory data management, facilitating seamless experimentation and analysis. By standardizing data capture and integrating with laboratory instruments, it enhances efficiency and ensures consistency across research teams.

Nanite is a pioneering biotechnology company specializing in the development of non-viral gene delivery systems. Their proprietary platform, SAYER™, integrates artificial intelligence with high-throughput experimental and computational methods to design programmable polymer nanoparticles (PNPs). These PNPs are engineered to deliver a wide range of genetic cargoes with tissue specificity, offering a safer and more efficient alternative to traditional viral vectors. By harnessing AI-driven design,

ZipBio is a biotechnology company founded in 2023, dedicated to revolutionizing therapeutic development through the use of generative AI. Their proprietary COMPACT™ platform compresses complex biological structures into smaller, de novo-designed proteins that retain full functionality. This innovation addresses the size limitations of traditional therapeutics, enhancing delivery and effectiveness for hard-to-treat diseases.

Biolevate is a pioneering company dedicated to integrating ethical artificial intelligence (AI) into the healthcare sector, aiming to create simple, secure, and collaborative solutions that accelerate medical advancements for a more accessible world. By harnessing the power of AI, Biolevate addresses the complex challenges faced by the life sciences industry, offering tailored solutions that enhance efficiency, compliance, and innovation.

Ignota Labs is a pioneering company dedicated to revitalizing promising yet abandoned drug candidates by addressing safety concerns that have halted their development. Leveraging their proprietary AI platform, SAFEPATH, Ignota Labs integrates deep learning with bioinformatics and cheminformatics to uncover and resolve the underlying mechanisms of drug toxicity. This innovative approach enables the company to rescue drugs that have failed in preclinical or early-phase clinical trials due to safet

Formation Bio is a pharmaceutical company dedicated to revolutionizing drug development by integrating advanced technology and artificial intelligence (AI) across the entire development lifecycle. By leveraging a modern data stack, large language models (LLMs), and AI agents, Formation Bio aims to accelerate the delivery of new treatments to patients more efficiently.

Reshape Biotech offers an AI-powered platform that automates the imaging and analysis of petri and microtiter plates, enabling laboratories to capture high-resolution images, extract data instantly, and obtain reliable results.